Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Experimental Medicine|December 2, 2015
Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancyPriscilla N Kelly, Donna L Romero, Yibin Yang, et al.
Haematologica|August 3, 2023
Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclaxFen Zhu, Jennifer L Crombie, Wei Ni, et al.
Leukemia|October 2, 2019
Recent BCR stimulation induces a negative autoregulatory loop via FBXO10 mediated degradation of HGALFengjie Guo, Yuan Luo, Xiaoyu Jiang, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Combination fedratinib and venetoclax has activity against human B-ALL with high FLT3 expressionSean P Rinella, Haley C Bell, Nicholas J Hess, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2018
Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphomaLi Lu, Fen Zhu, Meili Zhang, et al.
The Journal of Biological Chemistry|December 28, 2017
Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myelomaMailee Huynh, Chorom Pak, Stephanie Markovina, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2016
Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2Daniel J Hodson, Arthur L Shaffer, Wenming Xiao, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2007
A mutation in a chromosome condensin II subunit, kleisin beta, specifically disrupts T cell developmentKatharine M Gosling, Lydia E Makaroff, Angelo Theodoratos, et al.
Leukemia|April 17, 2026
PRMT5 inhibition sensitizes B-cell lymphoma cells to ferroptosisYunxia Liu, Ruoyu Chen, Xiaoyue Gao, et al.
Cell Reports. Medicine|March 30, 2024
Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphomaNguyet-Minh Hoang, Yunxia Liu, Paul D Bates, et al.
Pageof 4